soluble human leukemia inhibitory factor from recombinant Escherichia coli using thioredoxin as fusion partner. Protein Expr Purif 73, no. 1:51. Wernet, P., Trapp, T., Zweigerdt, R., Mann, J., and Trompeter,
Research at the Department of Human Genetics Our scientific findings make an important contribution to the understanding of ultra-rare genetic diseases, the identification of risk factors for cancer a